Literature DB >> 20140014

Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.

J van Dieck1, T Brandt, D P Teufel, D B Veprintsev, A C Joerger, A R Fersht.   

Abstract

S100 proteins modulate p53 activity by interacting with its tetramerization (p53TET, residues 325-355) and transactivation (residues 1-57) domains. In this study, we characterized biophysically the binding of S100A1, S100A2, S100A4, S100A6 and S100B to homologous domains of p63 and p73 in vitro by fluorescence anisotropy, analytical ultracentrifugation and analytical gel filtration. We found that S100A1, S100A2, S100A4, S100A6 and S100B proteins bound different p63 and p73 tetramerization domain variants and naturally occurring isoforms with varying affinities in a calcium-dependent manner. Additional interactions were observed with peptides derived from the p63 and p73 N-terminal transactivation domains. Importantly, S100 proteins bound p63 and p73 with different affinities in their different oligomeric states, similarly to the differential modes of binding to p53. On the basis of our data, we hypothesize that S100 proteins regulate the oligomerization state of all three p53 family members and their isoforms, with a potential physiological relevance in developmental and disease-related processes. The regulation of the p53 family by S100 is complicated and depends on the target preference of each individual S100 protein, the concentration of the proteins and calcium, as well as the splicing variation of p63 or p73. Our results outlining the complexity of the interaction should be considered when studying the functional effects of S100 proteins in their biological context.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140014     DOI: 10.1038/onc.2009.490

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion.

Authors:  Reniqua P House; Maria Pozzuto; Purvi Patel; Natalya G Dulyaninova; Zhong-Hua Li; Wendy D Zencheck; Michele I Vitolo; David J Weber; Anne R Bresnick
Journal:  Biochemistry       Date:  2011-07-13       Impact factor: 3.162

Review 2.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

3.  Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.

Authors:  Gu Xiao; George K Annor; Kimberly Fung; Outi Keinänen; Brian M Zeglis; Jill Bargonetti
Journal:  Mol Pharm       Date:  2020-12-08       Impact factor: 4.939

4.  The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.

Authors:  Jing Lin; Qingyuan Yang; Paul T Wilder; France Carrier; David J Weber
Journal:  J Biol Chem       Date:  2010-06-29       Impact factor: 5.157

5.  In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction.

Authors:  Paul T Wilder; Thomas H Charpentier; Melissa A Liriano; Kira Gianni; Kristen M Varney; Edwin Pozharski; Andrew Coop; Eric A Toth; Alex D Mackerell; David J Weber
Journal:  Int J High Throughput Screen       Date:  2010-07-07

6.  Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human PBMC-SCID mice.

Authors:  H Tamai; K Miyake; H Yamaguchi; T Shimada; K Dan; K Inokuchi
Journal:  Bone Marrow Transplant       Date:  2014-03-03       Impact factor: 5.483

7.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17

8.  Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B.

Authors:  Lucas N Wafer; Werner W Streicher; Scott A McCallum; George I Makhatadze
Journal:  Biochemistry       Date:  2012-08-29       Impact factor: 3.162

9.  Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization.

Authors:  Lucas N Wafer; Franco O Tzul; Pranav P Pandharipande; George I Makhatadze
Journal:  Biochemistry       Date:  2013-08-15       Impact factor: 3.162

10.  Effects of Levetiracetam on neural tube development and closure of the chick embryos in ovo.

Authors:  Füsun Demirçivi Ozer; Adıgüzel Demirel; Ozlem Yılmaz Dilsiz; Murat Aydın; Nail Özdemir; Yiğit Uyanıkgil; Meral Baka
Journal:  Childs Nerv Syst       Date:  2012-05-09       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.